Lorazepam Tablet
Product Images NDC 71610-842

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-842). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0842 15)

Label (71610 0842 15)
Lorazepam USP 2 mg oral tablets packaging label showing 15 tablets. Label includes NDC 71610-842-15, manufacturer Ohm Laboratories, Inc., New Brunswick, NJ, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. Storage instructions and safety warnings are also visible.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

1 (Spl Lorazepam Tablet Structure)

1 (Spl Lorazepam Tablet Structure)
Chemical structure of Lorazepam, a benzodiazepine. The diagram shows benzene rings with chlorine substitutions and functional groups representing Lorazepam's molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.